 MRVL had fallen more than 50 from its December 2021 highs, which is justified as it was overvalued. The market correctly anticipated that it could not sustain its growth momentum. However, we believe the digestion in its growth premium has likely bottomed out in July. Therefore, we are confident that Marvells growth cadence should recover from H123. 